Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

'Mad Money' host Jim Cramer weighs in on stock including: Lincoln Electric, Caesars Entertainment, CRISPR, and Seagate. This ...

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you ...

Vertex is paying Orna $65 million upfront, in part via convertible note, according to a Jan. 7 release. Orna—which acquired ...

JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease: Hyogo, Japan Tuesday, January 7, 20 ...

For modern biotherapeutics, cell line development workflows must include more than just automated liquid handling.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

AlphaFold solved a structural biology riddle: predicting protein structure. And yet, CASP, a global competition born to solve ...

This study addresses fundamental questions surrounding otitis media effusion in Down syndrome, identifying DYRK1A as a key gene involved in the condition. The findings are compelling, highlighting ...

Today has seen a lot of movement in Russia's Kursk region, where Ukraine launched an offensive last year. We'll be back tomorrow with more updates on the war in Ukraine. But here is a look at the ...

Trudeau to Resign as Canada’s Prime Minister: ‘It’s Time for a Reset’ Justin Trudeau announced that he was also stepping down as the leader of Canada’s Liberal Party. He will remain in ...